<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0484-7903</journal-id>
<journal-title><![CDATA[Revista mexicana de anestesiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. anestesiol.]]></abbrev-journal-title>
<issn>0484-7903</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Anestesiología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0484-79032020000100016</article-id>
<article-id pub-id-type="doi">10.35366/cma201c</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Dexmedetomidina subcutánea. ¿Es útil en el perioperatorio del paciente pediátrico?]]></article-title>
<article-title xml:lang="en"><![CDATA[Subcutaneous dexmedetomidine. Is it useful in the perioperative of the pediatric patient?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Álvarez-Betancourt]]></surname>
<given-names><![CDATA[Ana Elsa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez-Hernández]]></surname>
<given-names><![CDATA[Eloy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López-González]]></surname>
<given-names><![CDATA[Brenda Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Moreno]]></surname>
<given-names><![CDATA[Óscar Armando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Civil de Guadalajara «Fray Antonio Alcalde»  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Civil de Guadalajara «Fray Antonio Alcalde» Servicio de Anestesiología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Centro Médico Nacional de Occidente Hospital de Pediatría Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>México</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Centro Médico Nacional de Occidente Unidad Médica de Alta Especialidad servicio de Anestesiología]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>43</volume>
<numero>1</numero>
<fpage>16</fpage>
<lpage>22</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0484-79032020000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0484-79032020000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0484-79032020000100016&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La dexmedetomidina es un alfa 2 agonista, al cual se le han atribuido diversos efectos clínicos (antinociceptivos, hipnótico-sedantes, anestésicos, cardiovasculares, ventilatorios, renales, endocrinos y oculares), variados mecanismos de acción, y versatilidad en sus vías de administración, por lo que ha sido utilizada como adyuvante durante el período perioperatorio, ya que proporciona sedación, ansiólisis, prevención de delirio y analgesia. En este estudio, se evaluó exclusivamente la administración subcutánea como adyuvante, sus implicaciones sobre el dolor y la comodidad en el postoperatorio.  Material y métodos:  Se realizó una serie de casos de forma prospectiva, observacional, descriptiva, en donde se estudiaron pacientes de 3-15 años de edad, de ambos géneros, programados para cirugía de abdomen bajo, ASA I-II. Se dividieron en cuatro grupos: grupo I recibió placebo; II, III y IV clorhidrato de dexmedetomidina de 1, 1.5 y 2 &#956;g/kg, respectivamente. El placebo o clorhidrato de dexmedetomidina se administraron vía subcutánea en región deltoidea. En el postoperatorio inmediato se tomaron en cuenta, por única vez, la escala de sedación, delirio y confort, para valorar durante la emersión el impacto de la dosis de dexmedetomidina. Después se realizó la medición y registro en tres tiempos distintos de los parámetros hemodinámicos (TA, FC, SpO2), así como la intensidad del dolor; la primera al finalizar el procedimiento quirúrgico, a las 12 y a las 24 horas.  Conclusiones:  La administración subcutánea de dexmedetomidina en el paciente pediátrico es una alternativa segura y eficaz, que preserva la función respiratoria, con adecuado grado de sedación, y estabilidad hemodinámica, mejorando la analgesia (hasta 24 horas) posterior al evento quirúrgico, menor agitación y delirio en el postoperatorio, lo que resulta en mayor comodidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract. Introduction: Dexmedetomidine is an alpha 2 agonist, several clinical effects has been attributed (antinociceptive, hypnotic-sedative, anesthetic, cardiovascular, ventilatory, renal, endocrine and ocular), varied mechanisms of action, and versatility in its administration pathways. It has been used as adjuvant during the perioperative period providing sedation, anxiolysis, delirium prevention and analgesia. In this study we evaluated exclusively subcutaneous administration as an adjuvant, its implications on pain and postoperative comfort (PO). Material and methods: A prospective, observational, descriptive series of cases was performed. Patients 3-15 years of age, scheduled for low abdominal surgery, both genders, ASA I, II. They were divided into four groups: Group I. placebo, group II, III and IV received dexmedetomidine hydrochloride 1, 1.5 and 2 &#956;g/kg respectively. The placebo or dexmedetomidine hydrochloride was administered subcutaneously in the deltoid region. The sedation, delirium and comfort scale were titrated in the immediate postoperative PO to assess the impact of the dose of dexmedetomidine during the emersion. Subsequently, three evaluations of the hemodynamic parameters (TA, FC, SpO2) were performed, as well as the intensity of the pain, the first one at the end of the surgical procedure, 12 and at 24 hours later. Conclusions: Subcutaneous administration of dexmedetomidine in the pediatric patient is a safe and effective alternative, preserving respiratory function, with adequate sedation, hemodynamic stability, improving analgesia (up to 24 hours) after the surgical event, less agitation and delirium in the postoperative resulting in greater comfort.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Dexmedetomidina]]></kwd>
<kwd lng="es"><![CDATA[analgesia]]></kwd>
<kwd lng="es"><![CDATA[subcutánea]]></kwd>
<kwd lng="es"><![CDATA[sedación,dolor]]></kwd>
<kwd lng="es"><![CDATA[pediatría]]></kwd>
<kwd lng="en"><![CDATA[Dexmedetomidine]]></kwd>
<kwd lng="en"><![CDATA[analgesia]]></kwd>
<kwd lng="en"><![CDATA[subcutaneous]]></kwd>
<kwd lng="en"><![CDATA[sedation]]></kwd>
<kwd lng="en"><![CDATA[pain]]></kwd>
<kwd lng="en"><![CDATA[pediatrics]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-González]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Hernández]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Moreno]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
</person-group>
<source><![CDATA[Dexmedetomidina por vía Subcutánea como coadyuvante anestésico en el paciente pediátrico después de apendicectomía abierta]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Guadalajara, México ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de Guadalajara]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shukry]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexmedetomidine as a total intravenous anesthetic in infants]]></article-title>
<source><![CDATA[Paediatr Anaesth]]></source>
<year>2007</year>
<volume>17</volume>
<page-range>581-3</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munro]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Tirotta]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Felix]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children]]></article-title>
<source><![CDATA[Paediatr Anaesth]]></source>
<year>2007</year>
<volume>17</volume>
<page-range>109-12</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Doyle]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Bekker]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Awake craniotomy with dexmedetomidine in pediatric patients]]></article-title>
<source><![CDATA[J Neurosurg Anesthesiol]]></source>
<year>2014</year>
<volume>15</volume>
<page-range>263-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexmedetomidina, un fármaco prometedor]]></article-title>
<source><![CDATA[Rev Esp Anestesiol Reanim]]></source>
<year>2002</year>
<volume>49</volume>
<page-range>407-20</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrillo-Torres]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Pliego-Sánchez]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Gallegos-Allier]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilidad de la dexmedetomidina en diversos contextos en la medicina actual]]></article-title>
<source><![CDATA[Rev Mex Anestesiol]]></source>
<year>2014</year>
<volume>37</volume>
<page-range>27-34</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortinez]]></surname>
<given-names><![CDATA[LI]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[YW]]></given-names>
</name>
<name>
<surname><![CDATA[Sum-Ping]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Keifer]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Macleod]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2004</year>
<volume>101</volume>
<page-range>1077-83</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Snapir]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Posti]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kentala]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Koskenvuo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sundell]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tuunanen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2006</year>
<volume>105</volume>
<page-range>902-quiz 1069-1070</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hogue]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tlake]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Domitrovich]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sessier]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autonomic nervous system responses during sedative infusions of dexmedetomidina]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2002</year>
<volume>97</volume>
<page-range>592-8</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramsay]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bariatric surgery: The role of dexmedetomidine]]></article-title>
<source><![CDATA[Critical Care Medicine]]></source>
<year>2006</year>
<volume>25</volume>
<page-range>51-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brunton]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Lazo]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
</person-group>
<source><![CDATA[Goodman &amp; Gilman. Las bases farmacológicas de la terapéutica]]></source>
<year>2010</year>
<edition>11</edition>
<page-range>4-6</page-range><publisher-name><![CDATA[&#924;graw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kivisto]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
<name>
<surname><![CDATA[Kallio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Neuvonen]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine]]></article-title>
<source><![CDATA[Eur J Clin Pbarmacol]]></source>
<year>1994</year>
<volume>46</volume>
<page-range>345-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez-Vega]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Grandeño-Vega]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Villareal-Careaga]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexmedetomidina subcutánea para disminuir los requerimientos de halogenados y narcóticos en anestesia general balanceada, para cirugía de mastectomía]]></article-title>
<source><![CDATA[Arch Salud Sin]]></source>
<year>2011</year>
<volume>5</volume>
<page-range>13-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schanabel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reichi]]></surname>
<given-names><![CDATA[SU]]></given-names>
</name>
<name>
<surname><![CDATA[Poepping]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy and safety of intraoperative dexmedetomidne for acute postoperative pain in children]]></article-title>
<source><![CDATA[Paediatr Anaesth]]></source>
<year>2013</year>
<volume>23</volume>
<page-range>170-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shagufta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Erum]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexmedetomidine in current anaestesia practice: a review]]></article-title>
<source><![CDATA[J Clin Diagn Res]]></source>
<year>2014</year>
<volume>8</volume>
<page-range>GE01-4</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Liley]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sanders]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Sleigh]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<source><![CDATA[Multi-channel brain electrical activity in a 5 year old preceding an episode of emergence delirium]]></source>
<year>2012</year>
<publisher-name><![CDATA[ASA Annual congress abstract A951]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dahmani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Delivet]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hilly]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emergence delirium in children: an update]]></article-title>
<source><![CDATA[Curr Opin Anaesthesiol]]></source>
<year>2014</year>
<volume>27</volume>
<page-range>309-15</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ibacache]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Munoz]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Brandes]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Single-dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children]]></article-title>
<source><![CDATA[Anesth Analg]]></source>
<year>2004</year>
<volume>98</volume>
<page-range>60-3</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guler]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Akin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tosun]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Ors]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Esmaoglu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Boyaci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy]]></article-title>
<source><![CDATA[Paediatr Anaesth]]></source>
<year>2005</year>
<volume>15</volume>
<page-range>762-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
